Search results
About Avellino Avellino Lab USA, Inc. is a global leader in genetic molecular diagnostics at the forefront of precision medicine for eye care. With a long-term mission to develop personalized approaches to
1505 Adams Drive, Suite B2. Menlo Park, CA 94025. Home. Company
Allouche brings to Avellino over 20 years of experience in finance leadership in both public and pre-IPO companies, including diagnostics and biopharmaceutical. He most recently served as CFO at Dermavant Sciences and held finance leadership roles at Revance Therapeuthics and CareDx.
Oct 4, 2021 · Avellino is acting to make workplace and patient care safety a reality for everyone. That’s why we created Avellino ACTS Safety Program to provide testing and communication tools to help you keep the people you are responsible for safe and confident that your organization is committed to safety. THE AVELLINO A.C.T.S. PROGRAM
This quarter, the company begins rolling out the availability of AvaGen in a controlled launch leading to nationwide availability of the genetic diagnostic in 2020. AvaGen is the first commercially available genetic diagnostic test of its kind for keratoconus and corneal dystrophies.
Simultaneous detection of COVID-19 and influenza viruses. MENLO PARK, CALIFORNIA (November 9, 2020) — Avellino announced today that the company has developed a novel multi-panel RT-PCR-based virus assay, AvellinoCoV2-Respiratory, which has been validated following the U.S. Food and Drug Administration’s Policy for Diagnostics Testing in ...
Dec 15, 2020 · MENLO PARK, CALIFORNIA (December 15, 2020) — Avellino announced today the appointment of three new members to its Board of Directors. In addition, the company announced a new Chief Executive Officer and President, and Chief Financial Officer and Treasurer. All appointments are effective December 2020.
Eric joins Avellino Labs from Alcon, bringing 20 years of product development and commercialization experience in the ophthalmic surgical industry. Eric started his career in patient care and moved into the industry in 1999 with Summit Technology, one of the first excimer laser manufacturers.
Avellino Labs continues to expand its diagnostics capabilities, building on the success of the world's first DNA test to confirm the presence of genetic indicators that are positively associated with corneal dystrophies, providing life -
Susan (Siw) Daniels is Avellino’s Chief Scientific Officer, bringing more than 25 years of experience developing molecular disease technology and diagnostics solutions.
